Enochian Biosciences Inc. (ENOB) NASDAQ

$0.70 - (-)

Market Cap: $40.80M

As of 08/04/23 12:00 AM EDT. Market closed.

(ENOB)

Enochian Biosciences Inc. (ENOB)
NASDAQ

$0.70
- (-)

Market Cap: $40.80M

As of 08/04/23 12:00 AM EDT. Market closed.

Add to Portfolio

enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$313,775
CEO Compensation (Total)
$426,612
URL
Address
Century City Medical Plaza, 2080 Century City East, California, Los Angeles, 90067.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Eric Leire
CEO Compensation (Base)
$313,775
CEO Compensation (Total)
$426,612
Address
Century City Medical Plaza, 2080 Century City East, California, Los Angeles, 90067.
PRICE CHART FOR ENOCHIAN BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.72
Previous Close
$0.70
Days Range
$0.70 - $0.75
52 week range
$0.39 - $2.99
Volume
88,381
Avg. Volume (30 days)
436,764
Market Cap
$40.80M
Dividend Yield
-
P/E
-
Shares Outstanding
58,283,591
Open
$0.72
Previous Close
$0.70
Days Range
$0.70 - $0.75
52 week range
$0.39 - $2.99
Volume
88,381
Avg. Volume (30 days)
436,764
Market Cap
$40.80M
Dividend Yield
-
P/E
-
Shares Outstanding
58,283,591
FINANCIAL STATEMENTS FOR ENOCHIAN BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ENOCHIAN BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sindlev ReneDirectorFeb 20, 2024 Option Exercise$0.53471,699250,00013,605,297Feb 22, 2024, 04:35 PM
Sindlev ReneDirectorJun 26, 2023 Option Exercise$0.531,886,7941,000,00112,432,338Jun 27, 2023, 08:29 PM
Sindlev ReneDirectorMar 17, 2023 Option Exercise$1.14877,1931,000,00010,545,544Mar 21, 2023, 09:39 PM
Gumrukcu Serhat10% OwnerMay 18, 2022 Sale$8.00253,4932,027,94412,401,552May 20, 2022, 09:37 PM
Sindlev ReneDirectorMay 18, 2022 Buy$8.00128,4931,027,944128,493May 20, 2022, 09:32 PM
Sindlev ReneDirectorMay 18, 2022 Buy$8.00125,0001,000,000125,000May 20, 2022, 09:32 PM
Sandler Carl ForestDirectorMar 22, 2022 Sale$9.061,92717,4593,187,487Mar 24, 2022, 04:30 PM
Sandler Carl ForestDirectorFeb 23, 2022 Sale$9.006543,189,414Feb 23, 2022, 05:18 PM
Sandler Carl ForestDirectorFeb 18, 2022 Sale$9.036,79261,3483,189,420Feb 23, 2022, 05:18 PM
Sindlev ReneDirectorJul 30, 2019 Option Exercise$1.303,092,3074,019,9999,668,351Aug 01, 2019, 09:26 PM
Sindlev ReneDirectorJun 04, 2019 Buy$6.7031,500211,0506,576,044Jun 06, 2019, 02:26 PM
Sindlev ReneDirectorMay 28, 2019 Buy$6.6136,200239,2826,484,544Jun 05, 2019, 02:08 PM
Sindlev ReneDirectorJun 03, 2019 Buy$6.7040,000268,0006,544,544Jun 05, 2019, 02:07 PM
Sindlev ReneDirectorMay 29, 2019 Buy$6.6020,000132,0006,504,544Jun 05, 2019, 02:06 PM
Sindlev ReneDirectorMay 24, 2019 Buy$6.255,01431,3386,448,344Jun 05, 2019, 02:05 PM
Sindlev ReneDirectorMay 28, 2019 Buy$6.6136,200239,2826,479,530May 30, 2019, 04:05 PM
Sindlev ReneDirectorMay 22, 2019 Buy$5.765002,8806,443,330May 24, 2019, 03:39 PM
Sindlev ReneDirectorMay 21, 2019 Buy$5.7520,000115,0006,442,830May 23, 2019, 05:39 PM
Gronfeldt-Sorensen HenrikDirectorJan 10, 2019 Buy$2.0050,000100,00050,000Jan 11, 2019, 05:37 PM
Sindlev ReneDirectorDec 27, 2018 Buy$8.0092,968743,7445,115,137Dec 28, 2018, 07:11 PM
Sindlev ReneDirectorDec 27, 2018 Option Exercise$1.301,307,6931,700,0016,422,830Dec 28, 2018, 07:11 PM
Sindlev ReneDirectorFeb 16, 2018 Option Exercise$1.441,250,0001,800,0005,020,869Nov 07, 2018, 09:13 PM
Sindlev ReneDirectorMay 21, 2018 Buy$5.381,3006,9945,022,169Nov 07, 2018, 09:13 PM
Leire, Eric Jean MarieChief Executive OfficerMay 17, 2018 Buy$5.407544,07272,246Jun 04, 2018, 04:50 PM
Leire, Eric Jean MarieChief Executive OfficerMay 16, 2018 Buy$5.501901,04571,492Jun 04, 2018, 04:50 PM
Leire, Eric Jean MarieChief Executive OfficerMay 24, 2018 Buy$5.277003,69173,246Jun 04, 2018, 04:50 PM
Leire, Eric Jean MarieChief Executive OfficerMay 22, 2018 Buy$5.253001,57572,546Jun 04, 2018, 04:50 PM
Leire, Eric Jean MarieChief Executive OfficerSep 20, 2017 Option Exercise$1.8062,687112,83771,302Sep 22, 2017, 04:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sindlev ReneDirector02/20/2024250,000
Sindlev ReneDirector06/26/20231,000,001
Sindlev ReneDirector03/17/20231,000,000
Gumrukcu Serhat10% Owner05/18/20222,027,944
Sindlev ReneDirector05/18/20221,027,944
Sindlev ReneDirector05/18/20221,000,000
Sandler Carl ForestDirector03/22/202217,459
Sandler Carl ForestDirector02/23/202254
Sandler Carl ForestDirector02/18/202261,348
Sindlev ReneDirector07/30/20194,019,999
Sindlev ReneDirector06/04/2019211,050
Sindlev ReneDirector05/28/2019239,282
Sindlev ReneDirector06/03/2019268,000
Sindlev ReneDirector05/29/2019132,000
Sindlev ReneDirector05/24/201931,338
Sindlev ReneDirector05/28/2019239,282
Sindlev ReneDirector05/22/20192,880
Sindlev ReneDirector05/21/2019115,000
Gronfeldt-Sorensen HenrikDirector01/10/2019100,000
Sindlev ReneDirector12/27/2018743,744
Sindlev ReneDirector12/27/20181,700,001
Sindlev ReneDirector02/16/20181,800,000
Sindlev ReneDirector05/21/20186,994
Leire, Eric Jean MarieChief Executive Officer05/17/20184,072
Leire, Eric Jean MarieChief Executive Officer05/16/20181,045
Leire, Eric Jean MarieChief Executive Officer05/24/20183,691
Leire, Eric Jean MarieChief Executive Officer05/22/20181,575
Leire, Eric Jean MarieChief Executive Officer09/20/2017112,837
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ENOCHIAN BIOSCIENCES INC
STOCK BUYBACKS FOR ENOCHIAN BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
0.84%
1Q
03/31/2023
09/30/2022
1.59%
2Q
03/31/2023
06/30/2022
5.74%
3Q
03/31/2023
03/31/2022
6.34%
4Q
03/31/2023
12/31/2021
6.98%
5Q
03/31/2023
09/30/2021
7.19%
6Q
03/31/2023
06/30/2021
15.42%
7Q
03/31/2023
03/31/2021
19.65%
8Q
03/31/2023
12/31/2020
19.96%
9Q
03/31/2023
09/30/2020
20.10%
10Q
03/31/2023
06/30/2020
20.42%
11Q
03/31/2023
03/31/2020
20.96%
12Q
03/31/2023
12/31/2019
20.96%
13Q
03/31/2023
09/30/2019
21.05%
14Q
03/31/2023
06/30/2019
43.53%
15Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
0.84%
1Q
09/30/2022
1.59%
2Q
06/30/2022
5.74%
3Q
03/31/2022
6.34%
4Q
12/31/2021
6.98%
5Q
09/30/2021
7.19%
6Q
06/30/2021
15.42%
7Q
03/31/2021
19.65%
8Q
12/31/2020
19.96%
9Q
09/30/2020
20.10%
10Q
06/30/2020
20.42%
11Q
03/31/2020
20.96%
12Q
12/31/2019
20.96%
13Q
09/30/2019
21.05%
14Q
06/30/2019
43.53%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ENOCHIAN BIOSCIENCES INC
LOADING...